| Literature DB >> 32865012 |
Jessica Hanae Zafra-Tanaka1, Ana Brañez-Condorena2, David R Soriano-Moreno3, Alvaro Taype-Rondan4.
Abstract
Transparency is a key factor to understand how recommendations were reached and to decide whether to adopt them or not. Currently, the American Diabetes Association (ADA) recommends the usage of real-time continuous glucose monitors in certain subgroups of people living with type 1 diabetes mellitus. In this commentary we sought to critically appraise this recommendation, mainly regarding the outcomes assessed, the evidence used for each outcome, and how the balance of benefits and harms was made. We found that the decision-making process followed to reach the ADA recommendation was not clear, and that the final recommendation does not seem to be supported in the assessed evidence.Entities:
Keywords: continuous glucose monitoring; diabetes mellitus; glycated hemoglobin A; hypoglycemia; type 1
Mesh:
Substances:
Year: 2020 PMID: 32865012 PMCID: PMC8655291 DOI: 10.1177/1932296820952065
Source DB: PubMed Journal: J Diabetes Sci Technol ISSN: 1932-2968